Rituxan Hycela (rituximab/hyaluronidase) - Biogen, Roche
From haematology to rheumatology: intravenous-to-subcutaneous rituximab transition in Sjögren disease-associated cryoglobulinaemic vasculitis. (PubMed, Rheumatology (Oxford)) - Sep 23, 2026 - No abstract available 
Journal • Hematological Disorders • Rheumatology • Sjogren's Syndrome • Vasculitis
http://www.ncbi.nlm.nih.gov/pubmed/42770865
 
Chun-Kuang Tsai; Wei-Sheng Chen; Yi-Fan Mai
 
Sep 23, 2026
 
Prev Next